Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	18.72	10.69	9.01
Graham Fair Price	-11.30	2037.28	2296.79
PEG	-10.82	-0.24	-0.22
Price/Book	5.64	0.62	0.59
Price/Cash Flow	-89.48	6.10	58.00
Prices/Earnings	53.79	6.43	4.18
Price/Sales	12.08	0.86	0.77
Price/FCF	-89.48	6.10	58.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-5.38	0.21	0.23
Operating Margin	-29.42	0.04	0.06
ROA	-31.79	0.01	0.02
ROE	0.04	0.02	-31.31
ROIC	0.03	0.01	-53.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.06	-0.04	58.22
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.29	-0.29	1.28
EPS QOQ	-0.19	-0.26	-38.78
FCF QOQ	-0.85	9.75	1048.79
Revenue QOQ	0.02	< 0.005	-48.89
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	68.72	61.83	-10.03
Days Sales Outstanding (DSO)	10.41	11.55	10.93
Inventory Turnover	1.31	1.46	11.15
Debt/Capitalization	0.25	0.24	-3.31
Quick Ratio	0.69	0.77	12.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2575.40	2756.22	7.02
Cash	1188.56	1463.01	23.09
Capex	-45.05	-48.99	-8.74
Free Cash Flow	26.27	282.25	974.51
Revenue	1982.66	1999.98	0.87
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.41	1.42	0.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.57	-3.08	-96.56
Naive Interpretation	Member

06 - Financial Health · Weak

Rating